Scopus Biopharma, Inc. is a biopharmaceutical company, which engages in the development of therapeutics targeting diseases with unmet medical needs. The company was founded on April 18, 2017 and is headquartered in New York, NY.
The current price of SCPS is 0.000100 USD — it has decreased by 50.00% in the past 24 hours. Watch Scopus Biopharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Scopus Biopharma, Inc. stocks are traded under the ticker SCPS.
SCPS stock has fallen by 50.00% compared to the previous week, the month change is a 95.24% fall, over the last year Scopus Biopharma, Inc. has showed a 99.80% decrease.
SCPS reached its all-time high on Dec 17, 2020 with the price of 47.860000 USD, and its all-time low was 0.000100 USD and was reached on Jun 4, 2024. View more price dynamics on SCPS chart. See other stocks reaching their highest and lowest prices.
SCPS stock is 100.00% volatile and has beta coefficient of −3.79. Track Scopus Biopharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Scopus Biopharma, Inc. there?
Scopus Biopharma, Inc. is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
No, SCPS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 29, 2024, the company has 13.00 employees. See our rating of the largest employees — is Scopus Biopharma, Inc. on this list?
Like other stocks, SCPS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Scopus Biopharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Scopus Biopharma, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Scopus Biopharma, Inc. stock shows the sell signal. See more of Scopus Biopharma, Inc. technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.